Workflow
Earnings Estimate Revisions
icon
Search documents
What Makes Hillman Solutions Corp. (HLMN) a New Buy Stock
ZACKS· 2025-09-25 17:01
Core Viewpoint - Hillman Solutions Corp. (HLMN) has received a Zacks Rank 2 (Buy) upgrade, indicating a positive trend in earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system is based on changes in earnings estimates, which are closely correlated with stock price movements, particularly due to institutional investors' reliance on these estimates for valuation [4][6]. - For Hillman Solutions Corp., the recent upgrade reflects an improvement in the company's underlying business, suggesting that investor sentiment may drive the stock price higher [5][10]. Earnings Estimate Revisions - Hillman Solutions Corp. is projected to earn $0.55 per share for the fiscal year ending December 2025, with no year-over-year change expected [8]. - Over the past three months, the Zacks Consensus Estimate for Hillman Solutions Corp. has increased by 2.2%, indicating a positive trend in earnings estimates [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with only the top 20% of stocks receiving a "Strong Buy" or "Buy" rating, highlighting their potential for market-beating returns [9][10]. - Hillman Solutions Corp.'s upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a favorable outlook for the stock in the near term [10].
All You Need to Know About Collegium Pharmaceutical (COLL) Rating Upgrade to Strong Buy
ZACKS· 2025-09-25 17:01
Core Viewpoint - Collegium Pharmaceutical (COLL) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in buying or selling actions that affect stock prices [4]. Company Performance and Outlook - The upgrade for Collegium Pharmaceutical reflects an improvement in its underlying business, suggesting that investors may push the stock price higher due to this positive trend [5][10]. - The Zacks Consensus Estimate for Collegium Pharmaceutical indicates expected earnings of $7.03 per share for the fiscal year ending December 2025, with a 1.8% increase in estimates over the past three months [8]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Only the top 5% of Zacks-covered stocks receive a "Strong Buy" rating, positioning Collegium Pharmaceutical among the best candidates for potential market-beating returns [9][10].
CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's What You Should Know
ZACKS· 2025-09-25 17:01
Core Viewpoint - CAMP4 Therapeutics Corporation (CAMP) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of earnings estimate revisions, which are strongly correlated with near-term stock price movements [4][6]. - For CAMP, the recent increase in earnings estimates suggests an improvement in the company's underlying business, likely leading to a higher stock price [5]. Zacks Rating System - The Zacks Rank stock-rating system categorizes stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [7]. - The upgrade of CAMP to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating superior earnings estimate revisions and potential for market-beating returns [10]. Earnings Estimate Details - CAMP is projected to earn -$1.71 per share for the fiscal year ending December 2025, with no year-over-year change [8]. - Over the past three months, the Zacks Consensus Estimate for CAMP has increased by 31%, reflecting analysts' growing confidence in the company's earnings potential [8].
What Makes Atlas Copco (ATLKY) a New Buy Stock
ZACKS· 2025-09-25 17:01
Core Viewpoint - Atlas Copco AB has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of earnings estimate revisions, which are strongly correlated with near-term stock price movements [4][6]. - Rising earnings estimates for Atlas Copco suggest an improvement in the company's underlying business, likely leading to increased stock prices [5]. Zacks Rating System - The Zacks Rank stock-rating system classifies stocks into five groups based on earnings estimates, with a proven track record of generating significant returns for top-rated stocks [7][9]. - Only the top 20% of Zacks-covered stocks receive a "Strong Buy" or "Buy" rating, indicating superior earnings estimate revisions [10]. Earnings Estimate Details - Atlas Copco is projected to earn $0.58 per share for the fiscal year ending December 2025, with a 0.9% increase in the Zacks Consensus Estimate over the past three months [8].
Is It Worth Investing in XPeng (XPEV) Based on Wall Street's Bullish Views?
ZACKS· 2025-09-25 14:31
Core Viewpoint - Analyst recommendations play a significant role in influencing stock prices, but their reliability is questionable, particularly for XPeng Inc. (XPEV) [1][5][10] Group 1: Analyst Recommendations - XPeng has an average brokerage recommendation (ABR) of 1.88, indicating a consensus between Strong Buy and Buy, based on 20 brokerage firms [2][4] - Out of the 20 recommendations, 11 are Strong Buy and 2 are Buy, representing 55% and 10% of total recommendations respectively [2] Group 2: Limitations of Brokerage Recommendations - Studies indicate that brokerage recommendations have limited success in guiding investors towards stocks with the highest price increase potential [5] - Analysts often exhibit a positive bias due to the vested interests of brokerage firms, leading to a disproportionate number of favorable ratings [6][10] - For every "Strong Sell" recommendation, there are five "Strong Buy" recommendations, suggesting a misalignment of interests with retail investors [6] Group 3: Zacks Rank vs. ABR - The Zacks Rank, which is based on earnings estimate revisions, is a more reliable indicator of near-term stock price performance compared to ABR [8][11] - Zacks Rank is displayed in whole numbers (1 to 5) and is updated more frequently, reflecting timely changes in earnings estimates [9][12] - XPeng currently holds a Zacks Rank of 3 (Hold), indicating cautious sentiment despite the favorable ABR [13][14]
ATI (ATI) Is Considered a Good Investment by Brokers: Is That True?
ZACKS· 2025-09-25 14:31
Core Viewpoint - The article discusses the reliability of brokerage recommendations and their influence on stock prices, specifically focusing on ATI's average brokerage recommendation (ABR) and its implications for investors [1][5]. Group 1: Brokerage Recommendations - ATI has an average brokerage recommendation (ABR) of 1.50, indicating a consensus between Strong Buy and Buy, based on recommendations from 12 brokerage firms [2]. - Out of the 12 recommendations, 9 are classified as Strong Buy, accounting for 75% of the total recommendations [2]. - Despite the positive ABR, the article cautions against making investment decisions solely based on this metric, as studies show limited success of brokerage recommendations in predicting stock price increases [5]. Group 2: Analyst Bias and Zacks Rank - Analysts from brokerage firms tend to exhibit a strong positive bias in their ratings, with five "Strong Buy" recommendations for every "Strong Sell" recommendation, which may mislead investors [6][10]. - The Zacks Rank, a proprietary stock rating tool, categorizes stocks based on earnings estimate revisions and is considered a more effective indicator of near-term stock price performance compared to ABR [8][11]. - The Zacks Rank is updated more frequently than ABR, reflecting timely changes in earnings estimates, which can provide better insights into future price movements [12]. Group 3: ATI's Earnings Estimates - The Zacks Consensus Estimate for ATI's earnings for the current year remains unchanged at $3.06, suggesting stable analyst views on the company's earnings prospects [13]. - Due to the unchanged consensus estimate and other factors, ATI holds a Zacks Rank of 3 (Hold), indicating a cautious approach despite the Buy-equivalent ABR [14].
Is Most-Watched Stock Tutor Perini Corporation (TPC) Worth Betting on Now?
ZACKS· 2025-09-25 14:00
Core Viewpoint - Tutor Perini (TPC) has shown strong stock performance recently, with a notable increase in earnings estimates and revenue projections, suggesting potential for continued growth in the near future [2][5][11]. Earnings Estimate Revisions - For the current quarter, Tutor Perini is expected to report earnings of $0.96 per share, reflecting a significant increase of +150% year-over-year, with a 30-day change in the Zacks Consensus Estimate of +45.5% [5]. - The consensus earnings estimate for the current fiscal year stands at $3.78, indicating a year-over-year change of +220.8%, remaining unchanged over the last month [5]. - For the next fiscal year, the consensus earnings estimate is $4.63, representing a +22.5% change from the previous year, with a recent increase of +16.6% [6]. Revenue Growth Projections - The consensus sales estimate for the current quarter is $1.34 billion, indicating a year-over-year increase of +24.1% [11]. - Projected revenues for the current and next fiscal years are estimated at $5.24 billion and $6.1 billion, respectively, reflecting changes of +21.2% and +16.3% [11]. Last Reported Results and Surprise History - In the last reported quarter, Tutor Perini achieved revenues of $1.37 billion, a year-over-year increase of +21.8%, with an EPS of $1.41 compared to $0.19 a year ago [12]. - The company surpassed the Zacks Consensus Estimate for revenues by +11.55% and for EPS by +386.21% [12]. - Over the last four quarters, Tutor Perini exceeded consensus EPS estimates twice and revenue estimates twice [13]. Valuation - Tutor Perini is graded B in the Zacks Value Style Score, indicating it is trading at a discount compared to its peers [17]. - The evaluation of Tutor Perini's valuation multiples, such as P/E, P/S, and P/CF, suggests that the stock may be undervalued relative to its historical values and peers [15][16]. Bottom Line - The strong earnings estimate revisions and favorable revenue growth projections, along with a Zacks Rank of 1 (Strong Buy), suggest that Tutor Perini may outperform the broader market in the near term [7][18].
Is Most-Watched Stock Tenet Healthcare Corporation (THC) Worth Betting on Now?
ZACKS· 2025-09-25 14:00
Core Viewpoint - Tenet Healthcare (THC) has shown strong stock performance recently, with an 8.1% return over the past month, outperforming the S&P 500's 2.7% and the Zacks Medical - Hospital industry's 4.3% [1] Earnings Estimates - Tenet is expected to report earnings of $3.35 per share for the current quarter, reflecting a year-over-year increase of 14.3% [4] - The consensus earnings estimate for the current fiscal year is $15.54, indicating a year-over-year change of 30.8% [4] - For the next fiscal year, the consensus estimate is $15.96, showing a 2.7% increase from the previous year [5] Revenue Growth - The consensus sales estimate for the current quarter is $5.25 billion, representing a year-over-year change of 2.4% [10] - Estimated revenues for the current and next fiscal years are $21.15 billion and $22.14 billion, indicating changes of 2.4% and 4.6%, respectively [10] Recent Performance - In the last reported quarter, Tenet achieved revenues of $5.27 billion, a year-over-year increase of 3.3% [11] - The EPS for the same period was $4.02, compared to $2.31 a year ago, with a revenue surprise of 2.42% and an EPS surprise of 41.55% [11][12] Valuation - Tenet is graded A in the Zacks Value Style Score, indicating it is trading at a discount compared to its peers [16] - The evaluation of valuation multiples such as P/E, P/S, and P/CF suggests that Tenet's stock is fairly valued or undervalued relative to its historical values and peers [14][15] Conclusion - The Zacks Rank 2 for Tenet suggests potential outperformance in the near term, supported by strong earnings and revenue growth projections [17]
Jabil (JBL) Beats Q4 Earnings and Revenue Estimates
ZACKS· 2025-09-25 13:46
Financial Performance - Jabil reported quarterly earnings of $3.29 per share, exceeding the Zacks Consensus Estimate of $2.95 per share, and up from $2.30 per share a year ago, representing an earnings surprise of +11.53% [1] - The company posted revenues of $8.25 billion for the quarter ended August 2025, surpassing the Zacks Consensus Estimate by 7.67%, compared to $6.96 billion in the same quarter last year [2] Market Performance - Jabil shares have increased approximately 56.6% since the beginning of the year, significantly outperforming the S&P 500's gain of 12.9% [3] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $2.47 on revenues of $7.47 billion, and for the current fiscal year, it is $10.97 on revenues of $30.72 billion [7] - The Zacks Industry Rank indicates that the Electronics - Manufacturing Services sector is in the top 19% of over 250 Zacks industries, suggesting a favorable outlook for companies within this sector [8]
Ero Copper (ERO) Soars 7.9%: Is Further Upside Left in the Stock?
ZACKS· 2025-09-25 13:36
Group 1: Company Performance - Ero Copper Corp. (ERO) shares increased by 7.9% to close at $18.72, with a total gain of 19% over the past four weeks, supported by solid trading volume [1] - The company reported final assay results from its 28,000-meter Phase 1 drill program at the Furnas Copper-Gold Project, confirming high-grade continuity and expanding mineralization, indicating potential for a large-scale mining operation [2] - Ero Copper is expected to report quarterly earnings of $0.57 per share, reflecting a year-over-year increase of 111.1%, with revenues projected at $215.45 million, up 72.6% from the previous year [4] Group 2: Market Influences - The rise in Ero Copper's shares is also attributed to higher copper prices, which climbed 3.77% to $4.84 per pound due to supply concerns following Freeport-McMoRan's force majeure declaration at its Grasberg mine [3] - The consensus EPS estimate for Ero Copper has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [5] - Ero Copper holds a Zacks Rank of 3 (Hold), similar to Energy Fuels, which has also seen a recent increase in stock price [6]